Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
S., Kim, R
Morris G, Anderson G, Dean O, Berk M, Galecki P, Martin-Subero M, Maes M
Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response
Im still GF and basically Primal, but hand me a glass of wine and chocolate
Throughout the study, the mice had free access to standard laboratory granular diets and distilled water
Prevalence, awareness, treatment, and control rates, and comorbidities were analyzed
US$ 29.10
US$ 26.77
US$ 20.74
US$ 29.93
US$ 26.06
US$ 24.16
